BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15037767)

  • 1. Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.
    Rosonina E; Blencowe BJ
    RNA; 2004 Apr; 10(4):581-9. PubMed ID: 15037767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo.
    Rosonina E; Ip JY; Calarco JA; Bakowski MA; Emili A; McCracken S; Tucker P; Ingles CJ; Blencowe BJ
    Mol Cell Biol; 2005 Aug; 25(15):6734-46. PubMed ID: 16024807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.
    Fong N; Bentley DL
    Genes Dev; 2001 Jul; 15(14):1783-95. PubMed ID: 11459828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation.
    Bird G; Zorio DA; Bentley DL
    Mol Cell Biol; 2004 Oct; 24(20):8963-9. PubMed ID: 15456870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA.
    Kim E; Du L; Bregman DB; Warren SL
    J Cell Biol; 1997 Jan; 136(1):19-28. PubMed ID: 9008700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing.
    Du L; Warren SL
    J Cell Biol; 1997 Jan; 136(1):5-18. PubMed ID: 9008699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal domain of RNA polymerase II functions as a phosphorylation-dependent splicing activator in a heterologous protein.
    Millhouse S; Manley JL
    Mol Cell Biol; 2005 Jan; 25(2):533-44. PubMed ID: 15632056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple links between transcription and splicing.
    Kornblihtt AR; de la Mata M; Fededa JP; Munoz MJ; Nogues G
    RNA; 2004 Oct; 10(10):1489-98. PubMed ID: 15383674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions.
    Sánchez-Alvarez M; Goldstrohm AC; Garcia-Blanco MA; Suñé C
    Mol Cell Biol; 2006 Jul; 26(13):4998-5014. PubMed ID: 16782886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional unit of the RNA polymerase II C-terminal domain lies within heptapeptide pairs.
    Stiller JW; Cook MS
    Eukaryot Cell; 2004 Jun; 3(3):735-40. PubMed ID: 15189994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Phantom Mark: Enigmatic roles of phospho-Threonine 4 modification of the C-terminal domain of RNA polymerase II.
    Kempen RP; Dabas P; Ansari AZ
    Wiley Interdiscip Rev RNA; 2023; 14(4):e1771. PubMed ID: 36606410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA processing and human disease.
    Philips AV; Cooper TA
    Cell Mol Life Sci; 2000 Feb; 57(2):235-49. PubMed ID: 10766020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Pol II-dependent transcription efficiency fine-tunes A-to-I editing levels.
    Szabo B; Mandl TC; Woldrich B; Diensthuber G; Martin D; Jantsch MF; Licht K
    Genome Res; 2024 Mar; 34(2):231-242. PubMed ID: 38471738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcription.
    Zhang Q; Kim W; Panina S; Mayfield JE; Portz B; Zhang YJ
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.
    Zhao J; Hyman L; Moore C
    Microbiol Mol Biol Rev; 1999 Jun; 63(2):405-45. PubMed ID: 10357856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Views on the CTD Code.
    Zhang DW; Rodríguez-Molina JB; Tietjen JR; Nemec CM; Ansari AZ
    Genet Res Int; 2012; 2012():347214. PubMed ID: 22567385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiphosphorylation-Dependent Recognition of Anti-pS2 Antibodies against RNA Polymerase II C-Terminal Domain Revealed by Chemical Synthesis.
    Piemontese E; Herfort A; Perevedentseva Y; Möller HM; Seitz O
    J Am Chem Soc; 2024 May; 146(17):12074-12086. PubMed ID: 38639141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal tagging of RNA Polymerase II shapes transcriptomes more than C-terminal alterations.
    Callan-Sidat A; Zewdu E; Cavallaro M; Liu J; Hebenstreit D
    iScience; 2024 Jun; 27(6):109914. PubMed ID: 38799575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors.
    Bentley DL
    Curr Opin Cell Biol; 2005 Jun; 17(3):251-6. PubMed ID: 15901493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor condensates and signaling driven transcription.
    Mann R; Notani D
    Nucleus; 2023 Dec; 14(1):2205758. PubMed ID: 37129580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.